Novo Nordisk A/S (NVOD)
Market Open
15 Oct, 08:00 PM
BCBA BCBA Primary $
5. 97
+0.22
+3.8261%
$
- Market Cap
48.26 P/E Ratio
0.32% Div Yield
1,571 Volume
0 Eps
$ 5.75
Previous Close Want to track NVOD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S (NVOD) Statistics
Valuation metrics
Market Cap -
Enterprise value 18.11B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.77
Enterprise Value/Revenue 0.37
Enterprise Value/EBITDA 0.69
Overview
Shares outstanding -
Float 3.17B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 772
Average volume (90 days) 1.39K
Price summary
52-Week low 5.5
52-Week high 7.83
Beta 0.38
50-Day moving average 6.5
200-Day moving average 6.71
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 11.7
Trailing annual dividend yield 2.0348%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Aug 2026
Ex-Dividend Date 14 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.35%
Operating margin 0.43%
Operational effectiveness
Return on assets 0.19%
Return on equity 0.6%
Income Statement
Revenue (ttm) 49.47B
Revenue per share (ttm) 74.19
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 40.56B
EBITDA 26.08B
Net income to common (ttm) 17.49B
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.21%
Balance Sheet
Total cash (mrq) 6.76B
Total cash per share (mrq) 10.16
Total debt (mrq) 21.04B
Total Debt/Equity (mrq) 63.33
Current ratio (mrq) 0.87%
Book value per share (mrq) 7.52
Cash Flow
Cash flow statement 19.81B
Levered free cash flow (LFCF) 5.66B
2026 © Marketlog. All Rights Reserved.
